This section provides editorial clinical context based on Dr Narkienes professional remit
If symptoms are difficult to tolerate, a provider may recommend staying at a lower dose longer, delaying a dose increase, adjusting nutrition habits, or considering another treatment approach
u003cbru003ePatience and consistent medication use are essential
Pancreatitis risk Pancreatitis, inflammation of the pancreas, has been a concern with all incretin-based therapies since the earliest GLP-1 drugs reached market
For more information, read out press release here: #GreatChemistryCures To view or add a comment, sign in Recent announcement affecting those with Addison's Disease Hydrocortisone sodium phosphate injection (the pre-mixed hydrocortisone injection) has been discontinued Addison's Disease Self-Help Group (ADSHG) have released the following announcement: "Advanz Pharma has confirmed that following manufacturing issues, it has permanently discontinued the manufacture of hydrocortisone sodium phosphate in the UK